ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

November 19, 2004

In Brief: Fredrickson Okays NCI Reorganization, Plan At Hew; Miller Leave International Affairs Job

February 8, 1980

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

Obituary: Connie Curran, 67, C-Change Executive Director

November 21, 2014

Organ Systems Program Adds Workshops On Lung, Colorectal Cancer

January 26, 1990

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985